World first as patient receives pioneering lung cancer vaccine
July 30, 2026
July 30, 2026
LIVERPOOL, England, July 30 -- The University of Liverpool issued the following news release:
* * *
World first as patient receives pioneering lung cancer vaccine
*
Researchers and clinicians from the University of Liverpool and the Clatterbridge Cancer Centre (CCC) are leading a groundbreaking international clinical trial to investigate a personalised cancer vaccine for the most common type of lung cancer.
The team, which includes . . .
* * *
World first as patient receives pioneering lung cancer vaccine
*
Researchers and clinicians from the University of Liverpool and the Clatterbridge Cancer Centre (CCC) are leading a groundbreaking international clinical trial to investigate a personalised cancer vaccine for the most common type of lung cancer.
The team, which includes . . .